ENDONOVO THERAPEUTICS, INC. Proceeds from Issuance of Redeemable Preferred Stock
ENDONOVO THERAPEUTICS, INC. (ENDV) reported Proceeds from Issuance of Redeemable Preferred Stock of $50.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-04-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock · last filed 2021-11-19
- ENDONOVO THERAPEUTICS, INC. proceeds from issuance of redeemable preferred stock for the quarter ending 2020-12-31 was $0.00.
- ENDONOVO THERAPEUTICS, INC. proceeds from issuance of redeemable preferred stock for the quarter ending 2020-09-30 was $0.00.
- ENDONOVO THERAPEUTICS, INC. proceeds from issuance of redeemable preferred stock for the quarter ending 2020-06-30 was $0.00.
- ENDONOVO THERAPEUTICS, INC. proceeds from issuance of redeemable preferred stock for the quarter ending 2020-03-31 was $50.00K.
- ENDONOVO THERAPEUTICS, INC. proceeds from issuance of redeemable preferred stock for fiscal 2020 was $50.00K, a 80.39% decline from fiscal 2019.
- ENDONOVO THERAPEUTICS, INC. proceeds from issuance of redeemable preferred stock for fiscal 2019 was $255.00K, a 63.70% decline from fiscal 2018.
- ENDONOVO THERAPEUTICS, INC. proceeds from issuance of redeemable preferred stock for fiscal 2018 was $702.50K.
| Period end | Proceeds from Issuance of Redeemable Preferred Stock 3 month | Proceeds from Issuance of Redeemable Preferred Stock 6 month | Proceeds from Issuance of Redeemable Preferred Stock 9 month | Proceeds from Issuance of Redeemable Preferred Stock 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-13 | $0.00 derived: sum of 2 quarters · filed 2021-11-19 | $0.00 derived: sum of 3 quarters · filed 2021-11-19 | $50.00K 10-K · filed 2021-04-13 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | $0.00 derived: sum of 2 quarters · filed 2021-11-19 | $50.00K 10-Q · filed 2021-11-19 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-23 | $50.00K 10-Q · filed 2021-08-23 | ||
| 2020-03-31 | $50.00K 10-Q · filed 2021-05-24 | |||
| 2019-12-31 | $255.00K 10-K · filed 2021-04-13 | |||
| 2018-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-04 | $365.00K derived: sum of 2 quarters · filed 2020-05-04 | $702.50K 10-K · filed 2020-05-04 | |
| 2018-09-30 | $280.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-19 | $617.50K 10-Q · filed 2019-11-19 | ||
| 2018-06-30 | $337.50K 10-Q · filed 2019-08-13 |